ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
24/04/2026
Voltar para busca
Dado oficial do USPTO
VIVITROL2GETHER
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
44
Atualização mais recente
25/04/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
35, 36, 44, 45
Data de depósito
07/06/2017
Data de registro
16/07/2019
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
03/11/2025
Última transação
25/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
702
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
23/10/2017
Primeiro uso no comércio
23/10/2017
Código do desenho
3
Tipo de titular
03
Localização do titular
Waltham, MA, US
Examinador
ALLEN, BIANCA LEIGH
Localização atual
Historical data usage
Descrição da marca
The mark consists of two arcs over the word "VIVITROL2GETHER".
Titulares e representantes
Titulares
Alkermes, Inc.
Representantes
Norm J. Rich FOLEY & LARDNER LLP
Classificação técnica
Classes Nice
Classe 35Classe 36Classe 44Classe 45
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Logistics management in the field of medicationbusiness services in the nature of supporting the coordination of medication delivery to avoid product delivery delays; providing business administration information to patients and health care providers about medication reimbursement options regarding reimbursement procedures; providing information about pharmaceutical servicesproviding information about pharmacy authorization in the nature of prescription fulfillment and approval instructions for delivery of medication in the nature of accepting payment terms; appointment reminder services being support services for patients and for health care providers on behalf of their patients
Classe 36
Providing information about pharmaciesproviding a database featuring information about insurance coverage for pharmaceuticals in the nature of pharmacy selection based on patient health plan coverage requirements; providing information about pharmaceutical coverage by patient health plans; providing insurance administration information to patients and health care providers about medication reimbursement options; insurance services being support services for patients and for health care providers on behalf of their patientsproviding health benefit verification services to determine coverage of medication treatment; financial administration of medication reimbursement programs being support services for patients and for health care providers on behalf of their patientscoordinating medication reimbursement programs
Classe 44
Providing educational information in the field of medication treatment to health care providers and patients; providing educational information about productpharmaceutical products
Classe 45
Support services for health care providers and their patients in the nature of providing patient advocate and case management servicescoordinating the procurement of medication in the nature of coordinating with pharmacies to facilitate prescription fulfillment; providing patient advocate and case management services in the nature of support services for patients and for health care providers on behalf of their patientscoordinating the procurement and administration of medication in the nature of locating health care providers that can prescribe and/or administer prescribed medication
Publicações
Histórico de despachos e eventos da marca no USPTO.
44 publicações encontradas
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
03/11/2025
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
03/11/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/11/2025
E815
TEAS SECTION 8 & 15 RECEIVED
10/07/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
16/07/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
16/07/2019
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/06/2019
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/06/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/06/2019
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/06/2019
EX1G
SOU EXTENSION 1 GRANTED
04/06/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/06/2019
IUAF
USE AMENDMENT FILED
29/05/2019
EXT1
SOU EXTENSION 1 FILED
29/05/2019
EEXT
SOU TEAS EXTENSION RECEIVED
29/05/2019
EISU
TEAS STATEMENT OF USE RECEIVED
29/05/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/12/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/10/2018
PUBO
PUBLISHED FOR OPPOSITION
09/10/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
19/09/2018
ALIE
ASSIGNED TO LIE
04/09/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
20/08/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
20/08/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
20/08/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
20/08/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
20/08/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
27/07/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
27/07/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
27/07/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
27/07/2018
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
06/02/2018
GNFR
FINAL REFUSAL E-MAILED
06/02/2018
CNFR
FINAL REFUSAL WRITTEN
06/02/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
18/01/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
17/01/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
17/01/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
23/08/2017
GNRT
NON-FINAL ACTION E-MAILED
23/08/2017
CNRT
NON-FINAL ACTION WRITTEN
23/08/2017
DOCK
ASSIGNED TO EXAMINER
17/08/2017
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
15/06/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
14/06/2017
NWAP
NEW APPLICATION ENTERED
10/06/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace VIVITROL2GETHER ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.